Glucosamine inhibits glucokinase in vitro and produces a glucose-specific impairment of in vivo insulin secretion in rats - PubMed (original) (raw)
Glucosamine inhibits glucokinase in vitro and produces a glucose-specific impairment of in vivo insulin secretion in rats
B Balkan et al. Diabetes. 1994 Oct.
Abstract
A characteristic feature of non-insulin-dependent diabetes mellitus (NIDDM) is the lack of an acute insulin response to intravenous glucose with maintenance of the response to other secretagogues. It has been hypothesized that impaired glucose sensing stems from defective beta-cell glucokinase. It remains unclear whether decreased pancreatic glucokinase activity will produce defects of insulin secretion similar to those observed in NIDDM. In this study, the effects of glucosamine on glucokinase activity and on islet function were assessed in vitro and in vivo. Glucosamine (5 mmol/l) reduced glucokinase activity in islet homogenate and diminished the insulin response to glucose (200 mg/dl) by isolated islets, whereas the response to arginine (20 mmol/l at 100 mg/dl glucose) was unaffected. In conscious normal rats, glucosamine lowered plasma insulin, followed by an increase in blood glucose. Administration of glucosamine 10 min before an infusion of glucose (10 mg.min-1. 15 min) reduced the insulin response. The primary effect was an attenuation of the first-phase insulin response relative to the decreased basal insulin levels. Arginine (10 mg.min-1.15 min) induced biphasic insulin release in both groups. Although glucosamine slightly reduced the absolute insulin response, it was normal relative to preinfusion levels. In all experiments, glucagon secretion was unaffected by glucosamine. The results indicate that glucosamine inhibits beta-cell glucokinase activity in vitro. In addition, glucosamine impairs glucose- but not arginine-induced insulin secretion. We conclude that glucosamine, probably via a reduction of glucokinase activity, impairs insulin secretion in a manner comparable to that seen in NIDDM.
Similar articles
- Glucosamine infusion in rats mimics the beta-cell dysfunction of non-insulin-dependent diabetes mellitus.
Shankar RR, Zhu JS, Baron AD. Shankar RR, et al. Metabolism. 1998 May;47(5):573-7. doi: 10.1016/s0026-0495(98)90242-6. Metabolism. 1998. PMID: 9591749 - Glucosamine-induced inhibition of liver glucokinase impairs the ability of hyperglycemia to suppress endogenous glucose production.
Barzilai N, Hawkins M, Angelov I, Hu M, Rossetti L. Barzilai N, et al. Diabetes. 1996 Oct;45(10):1329-35. doi: 10.2337/diab.45.10.1329. Diabetes. 1996. PMID: 8826967 - Glucosamine-induced beta-cell dysfunction: a possible involvement of glucokinase or glucose-transporter type 2.
Yoshikawa H, Tajiri Y, Sako Y, Hashimato T, Umeda F, Nawata H. Yoshikawa H, et al. Pancreas. 2002 Apr;24(3):228-34. doi: 10.1097/00006676-200204000-00004. Pancreas. 2002. PMID: 11893929 - Lilly Lecture 1994. The beta-cell in diabetes: from molecular genetics to clinical research.
Polonsky KS. Polonsky KS. Diabetes. 1995 Jun;44(6):705-17. doi: 10.2337/diab.44.6.705. Diabetes. 1995. PMID: 7789637 Review. - Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes.
Matschinsky FM. Matschinsky FM. Diabetes. 1990 Jun;39(6):647-52. doi: 10.2337/diab.39.6.647. Diabetes. 1990. PMID: 2189759 Review.
Cited by
- Role of glucosamine in development of diabetic neuropathy independent of the aldose reductase pathway.
Mizukami H, Osonoi S, Takaku S, Yamagishi SI, Ogasawara S, Sango K, Chung S, Yagihashi S. Mizukami H, et al. Brain Commun. 2020 Oct 9;2(2):fcaa168. doi: 10.1093/braincomms/fcaa168. eCollection 2020. Brain Commun. 2020. PMID: 33305258 Free PMC article. - Reducing Glucokinase Activity Restores Endogenous Pulsatility and Enhances Insulin Secretion in Islets From db/db Mice.
Jahan I, Corbin KL, Bogart AM, Whitticar NB, Waters CD, Schildmeyer C, Vann NW, West HL, Law NC, Wiseman JS, Nunemaker CS. Jahan I, et al. Endocrinology. 2018 Nov 1;159(11):3747-3760. doi: 10.1210/en.2018-00589. Endocrinology. 2018. PMID: 30239634 Free PMC article. - Epigenetic switching by the metabolism-sensing factors in the generation of orexin neurons from mouse embryonic stem cells.
Hayakawa K, Hirosawa M, Tabei Y, Arai D, Tanaka S, Murakami N, Yagi S, Shiota K. Hayakawa K, et al. J Biol Chem. 2013 Jun 14;288(24):17099-110. doi: 10.1074/jbc.M113.455899. Epub 2013 Apr 26. J Biol Chem. 2013. PMID: 23625921 Free PMC article. - Brain glucose sensors play a significant role in the regulation of pancreatic glucose-stimulated insulin secretion.
Osundiji MA, Lam DD, Shaw J, Yueh CY, Markkula SP, Hurst P, Colliva C, Roda A, Heisler LK, Evans ML. Osundiji MA, et al. Diabetes. 2012 Feb;61(2):321-8. doi: 10.2337/db11-1050. Epub 2011 Dec 30. Diabetes. 2012. PMID: 22210318 Free PMC article. - Glucokinase inhibitor glucosamine stimulates feeding and activates hypothalamic neuropeptide Y and orexin neurons.
Zhou L, Yueh CY, Lam DD, Shaw J, Osundiji M, Garfield AS, Evans M, Heisler LK. Zhou L, et al. Behav Brain Res. 2011 Sep 12;222(1):274-8. doi: 10.1016/j.bbr.2011.03.043. Epub 2011 Apr 1. Behav Brain Res. 2011. PMID: 21440571 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous